Publication | Closed Access
TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties
128
Citations
13
References
2011
Year
MedicineReceptor Tyrosine KinaseMalignant Blood DisorderImmunologyPotent Anti-leukemic PropertiesAnti-cancer AgentAdult T-cell Leukemia-lymphomaPharmacologyRadiation OncologyCell SignalingNovel TherapyJak-stat Signaling Pathway
| Year | Citations | |
|---|---|---|
Page 1
Page 1